Clinical trial
fFN & E3 in the Prediction of PTB in Women With Twin Pregnancies Receiving 17OHP…
NCT00156000 · Obstetrix Medical Group, Industry · Withdrawn
Key facts
| NCT number | NCT00156000 |
|---|---|
| Title | fFN & E3 in the Prediction of PTB in Women With Twin Pregnancies Receiving 17OHP or Placebo |
| Official title | Fetal Fibronectin (fFN) and Salivary Estriol (E3) in the Prediction of Preterm Birth in Women With Twin Pregnancies Receiving 17-Alpha-Hydroxyprogesterone Caproate or Placebo |
| Lead sponsor | Obstetrix Medical Group, Industry |
| Collaborators | Adeza Biomedical Industry |
| Status | Withdrawn |
| Study type | Observational |
| Conditions | Preterm Delivery, Preterm Birth |
| Intervention type | Device |
| Interventions | Fetal Fibronectin, Salivary Estriol |
| Enrollment | 0 |
| Start date | Aug 1, 2005 |
| Primary completion | Feb 1, 2006 |
| Completion | Feb 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Dec 19, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: